Neurofibromatosis type I. Case report
Keywords:
neurocutaneous syndrome, neurofibromatosis, hereditary diseaseAbstract
A 25-year-old male patient presented with subcutaneous tumors in the limbs, dorso-vertebral region and difficulty walking. For this picture, he was admitted to the General Teaching Hospital "Dr. Agostinho Neto" for study and treatment. When the neurological examination was performed, there was presence of antalgic gait, supra and infraclavicular muscular atrophy, spinous, interosseous, tenar and bilateral hypothenar, subcutaneous tumors at the level of the neck, extremities and trunk, several "coffee with milk" spots, as well as a decrease of muscular strength 4/5 proximal distal of extremities. The radiological studies evidenced tumor bundle in the paravertebral and inguinal area, extraction and biopsy were performed, and neurofibromas were reported, diagnosing neurofibromatosis type I. Because it is one of the most frequent hereditary diseases, but less studied in our environment, it was decided to carry out this study.
Downloads
References
2. Flores Delgado E, Flores Miranda E. Neurofibroma del mesenterio en un paciente sin enfermedad de Von Recklinghausen. Rev Cubana Cir [en línea]. 2016 Dic [citado 19 Mar 2019]; 55(4): 325-333. Disponible en: http://scielo.sld.cu/pdf/cir/v55n4/cir07416.pdf
3. Reynods RM, Brouning GGP, Nawroz I, Campbell IW. Von Recklinghausen’s neurofibromatosis type 1. Lancet [en línea]. 2003 [citado 19 Mar 2019]; 361(9368):1552-4. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/12737880
4. Miraglia E, Moramarco A, Bianchini D, Iacovino C, Calvieri S, Giustini S. Retinitis pigmentosa: an unusual ocular manifestation in a patient with neurofibromatosis type 1. G Ital Dermatol Venereol [en línea]. 2017 Oct [citado 19 Mar 2019]; 152(5):543-54. DOI: 10.23736/S0392-0488.16.05360-8
5. Ehara Y, Yamamoto O, Kosaki K, Yoshida Y. Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1. J Dermatol [en línea]. 2018 Jan [citado 19 Mar 2019]; 45(1):53-57. DOI: 10.1111/1346-8138.14025
6. Tadini G, Brena M. Anemic nevus is a new diagnostic criterion for neurofibromatosis type 1. G Ital Dermatol Venereol [en línea]. 2017 Oct [citado 19 Mar 2019]; 152(5):548-549. DOI: 10.23736/S0392-0488.16.05379-7
7. Remillieux M, Durand C, Sartelet H, Piolat C, Bourgeois E, Pommier P, Hameury F, Dieterich K, Vidaud D, Perret C. Type 1 neurofibromatosis: Onset of two tumors before the age of 5 years. Arch Ped [en línea]. 2017 Oct [citado 19 Mar 2019]; 24(10):986-990. DOI: 10.1016/j.arcped.2017.08.009
8. Madeira Luciana G, Passos Renata LF, Souza Juliana F de, Rezende Nilton A, Rodrigues Luiz OC. Autonomic thermoregulatory dysfunction in neurofibromatosis type 1. Arq Neuro-Psiquiatr [en línea]. 2016 Oct [citado 19 Mar 2019]; 74(10):796-802. DOI: 10.1590/0004-282X20160122
9. Abaloun Y, Ajhoun Y. Lisch nodule in neurofibromatosis type 1. Pan Afr Med J [en línea]. 2017 [citado 19 Mar 2019]; 27:218. DOI: 10.11604/pamj.2017.27.218.11517
10.Gámez Rodríguez O, Correa Sánchez MG, Rodríguez Montalván M, Miyares Duvergel AG, Romero Calzado D. Neurofibromatosis de tipo 1 en un adulto joven. MEDISAN [en línea]. 2014 Abr [citado 19 Mar 2019]; 18(4):582-587. Disponible en: https://www.redalyc.org/pdf/3684/368445004018.pdf
11.Karnes P. Neurofibromatosis: a common neurocutaneous disorder. Mayo Clin Proc [en línea]. 1998 [citado 19 Mar 2019]; 73(11):1071-1076. DOI: 10.4065/73.11.1071
12.Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in pacientes with tuberous Sclerosis. Mayo Clin Proc [en línea]. 1991 [citado 19 Mar 2019]; 66(8):792-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/1861550
13.National Institutes of Health Consensus Development Conference. Neurofibromatosis: Conference Statement. Arch Neurol [en línea]. 1988 [citado 22 Mar 2019]; 45(5):575-578. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/3128965
